Background and Aims: Several widely used medications, with a relevant efficacy profile, are toxic to the peripheral nervous system and an even larger number of agents are suspected to be neurotoxic. There are concerns about the use of these drugs in patients with Charcot–Marie–Tooth disease (CMT), a hereditary motor and sensory neuropathy. This review provides evidence-based updated recommendations on this clinically relevant topic. Methods: A systematic review of the available studies/reports written in English was performed from July to September 2022 including in the search string all reported putative neurotoxic drugs. Results: The results of our systematic review provide evidence-based support for the statement that use of vincristine, and possibly paclitaxel, can occasionally induce an atypical, and more severe, course of drug-related peripheral neurotoxicity in CMT patients. It is therefore reasonable to recommend caution in the use of these compounds in CMT patients. However, no convincing evidence for a similar recommendation could be found for all other drugs. Interpretation: It is important that patients with CMT are not denied effective treatments that may prolong life expectancy for cancer or improve their health status if affected by non-oncological diseases. Accurate monitoring of peripheral nerve function in CMT patients treated with any neurotoxic agent remains mandatory to detect the earliest signs of neuropathy worsening and atypical clinical courses. Neurologists monitoring CMT patients as part of their normal care package or for natural history studies should keep detailed records of exposures to neurotoxic medications and support reporting of accelerated neuropathy progression if observed.

Cavaletti, G., Forsey, K., Alberti, P. (2023). Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 28(3 (September 2023)), 295-307 [10.1111/jns.12566].

Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review

Cavaletti, Guido
Primo
;
Alberti, Paola
Ultimo
2023

Abstract

Background and Aims: Several widely used medications, with a relevant efficacy profile, are toxic to the peripheral nervous system and an even larger number of agents are suspected to be neurotoxic. There are concerns about the use of these drugs in patients with Charcot–Marie–Tooth disease (CMT), a hereditary motor and sensory neuropathy. This review provides evidence-based updated recommendations on this clinically relevant topic. Methods: A systematic review of the available studies/reports written in English was performed from July to September 2022 including in the search string all reported putative neurotoxic drugs. Results: The results of our systematic review provide evidence-based support for the statement that use of vincristine, and possibly paclitaxel, can occasionally induce an atypical, and more severe, course of drug-related peripheral neurotoxicity in CMT patients. It is therefore reasonable to recommend caution in the use of these compounds in CMT patients. However, no convincing evidence for a similar recommendation could be found for all other drugs. Interpretation: It is important that patients with CMT are not denied effective treatments that may prolong life expectancy for cancer or improve their health status if affected by non-oncological diseases. Accurate monitoring of peripheral nerve function in CMT patients treated with any neurotoxic agent remains mandatory to detect the earliest signs of neuropathy worsening and atypical clinical courses. Neurologists monitoring CMT patients as part of their normal care package or for natural history studies should keep detailed records of exposures to neurotoxic medications and support reporting of accelerated neuropathy progression if observed.
Articolo in rivista - Review Essay
Charcot–Marie–Tooth disease; drugs; neurotoxicity; peripheral neuropathy; vincristine;
English
30-mag-2023
2023
28
3 (September 2023)
295
307
open
Cavaletti, G., Forsey, K., Alberti, P. (2023). Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 28(3 (September 2023)), 295-307 [10.1111/jns.12566].
File in questo prodotto:
File Dimensione Formato  
Cavaletti-2023-JPNS-AAM.pdf

accesso aperto

Descrizione: Review
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Creative Commons
Dimensione 445.4 kB
Formato Adobe PDF
445.4 kB Adobe PDF Visualizza/Apri
Cavaletti-2023-JPNS-VoR.pdf

accesso aperto

Descrizione: Review
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 898.81 kB
Formato Adobe PDF
898.81 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/418301
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
Social impact